DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,112 | +0.0% | 60,912 | -3.2% | 0.23% | +6.1% |
| Q2 2023 | $15,107 | -4.5% | 62,944 | +0.3% | 0.21% | -8.5% |
| Q1 2023 | $15,813 | -16.0% | 62,739 | -11.5% | 0.23% | -11.7% |
| Q4 2022 | $18,817 | -99.9% | 70,894 | +14.6% | 0.26% | -6.0% |
| Q3 2022 | $15,978,000 | +3.5% | 61,861 | +1.6% | 0.28% | +6.0% |
| Q2 2022 | $15,439,000 | -7.1% | 60,897 | +7.5% | 0.27% | +7.3% |
| Q1 2022 | $16,622,000 | +24.9% | 56,666 | +40.1% | 0.25% | +6.4% |
| Q4 2021 | $13,311,000 | +13.2% | 40,458 | +4.7% | 0.23% | +3.6% |
| Q3 2021 | $11,759,000 | +25.5% | 38,625 | +10.6% | 0.22% | +21.0% |
| Q2 2021 | $9,368,000 | +9.7% | 34,910 | -8.0% | 0.19% | +3.9% |
| Q1 2021 | $8,542,000 | +3.6% | 37,950 | +2.2% | 0.18% | -5.8% |
| Q4 2020 | $8,246,000 | +0.9% | 37,121 | -2.2% | 0.19% | -10.8% |
| Q3 2020 | $8,172,000 | +20.6% | 37,952 | -1.0% | 0.21% | +8.7% |
| Q2 2020 | $6,776,000 | +23.3% | 38,320 | -3.5% | 0.20% | +9.5% |
| Q1 2020 | $5,497,000 | -20.0% | 39,717 | -11.3% | 0.18% | +3.5% |
| Q4 2019 | $6,873,000 | +17.1% | 44,779 | +10.2% | 0.17% | -7.5% |
| Q3 2019 | $5,868,000 | -2.1% | 40,629 | -3.1% | 0.19% | -1.6% |
| Q2 2019 | $5,995,000 | -19.2% | 41,947 | -25.3% | 0.19% | -38.9% |
| Q1 2019 | $7,415,000 | +7.5% | 56,165 | -16.0% | 0.31% | -6.9% |
| Q4 2018 | $6,896,000 | -5.5% | 66,874 | -0.5% | 0.33% | -8.2% |
| Q3 2018 | $7,300,000 | +9.3% | 67,184 | -0.7% | 0.36% | +4.6% |
| Q2 2018 | $6,677,000 | -0.8% | 67,663 | -1.5% | 0.35% | -4.9% |
| Q1 2018 | $6,728,000 | +25776.9% | 68,721 | +22284.7% | 0.37% | +12100.0% |
| Q3 2015 | $26,000 | 0.0% | 307 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $26,000 | 0.0% | 307 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $26,000 | -76.8% | 307 | -76.5% | 0.00% | -75.0% |
| Q4 2014 | $112,000 | +13.1% | 1,307 | 0.0% | 0.01% | +9.1% |
| Q3 2014 | $99,000 | -5.7% | 1,307 | -2.2% | 0.01% | -21.4% |
| Q2 2014 | $105,000 | -11.8% | 1,337 | -16.0% | 0.01% | -12.5% |
| Q1 2014 | $119,000 | +6.2% | 1,591 | +9.6% | 0.02% | 0.0% |
| Q4 2013 | $112,000 | – | 1,452 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |